Anavex Life Sciences Corp (AVXL)

[falconer66a]

In Nature, no less.

Readers should understand that the new paper, telling of new, affirming data and findings about blarcamesine treating CNS conditions, in both transgenic mice and real humans, appears in Nature, one of the two biggest, most respected journals of science research globally. Nature is centered in Europe, The other one, Science, of the American Association for the Advancement of Science, is centered in the US.

Every researcher in the world dreams of getting a paper published in either of these journals. There is no better journal to be listed on one's resume or curriculum vitae. Rejection rates for both journals are very high; editors select only the best papers, having the most important and significant information.

In regards to blarcamesine, let the reader discern.